Tim-3 expression defines regulatory T cells in human tumors.
about
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic TargetingBeyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsThe role of regulatory T cells in cancer immunologyMinireview: Regulatory T Cells and Ovarian Cancer.Association of T-cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) polymorphisms with susceptibility and disease progression of HBV infection.TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis.Tim-3 and its role in regulating anti-tumor immunity.Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells.CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancerGlucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells.Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.Expression of Tim-3 in gastric cancer tissue and its relationship with prognosisApoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancerPD-1 marks dysfunctional regulatory T cells in malignant gliomas.Expression of immune checkpoints in T cells of esophageal cancer patientsTIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action.Natural and induced T regulatory cells in cancer.Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies.Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer.Induced regulatory T cells in inhibitory microenvironments created by cancer.Emerging immune checkpoints for cancer therapy.Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.T cell immunoglobulin domain and mucin domain-3 as an emerging target for immunotherapy in cancer management.Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages.Immune checkpoint inhibitors for cancer treatment.The relevance of Tim-3 polymorphisms and F protein to the outcomes of HCV infection.T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.T-cell immunoglobulin mucin-3 expression in invasive ductal breast carcinoma: Clinicopathological correlations and association with tumor infiltration by cytotoxic lymphocytes.Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence-free survival.Intraepithelial macrophage infiltration is related to a high number of regulatory T cells and promotes a progressive course of HPV-induced vulvar neoplasia.T-cell immunoglobulin mucin-3 as a potential inducer of the epithelial-mesenchymal transition in hepatocellular carcinoma.Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells.Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.Tim-3, Lag-3, and TIGIT.Immune regulation by Tim-3.Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression.Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.Next generation immune-checkpoints for cancer therapy.
P2860
Q26742012-C8454002-700F-47C2-A1E8-596B9A845929Q26782799-7774E7AE-5549-466B-86AD-5D0D8D1E2512Q27006663-A2AB1AA2-849B-49DD-A8C2-24AAF3B7534CQ30244214-AE1F98AB-C8B7-4C06-92BC-C056AA8D3355Q33670670-B194E7BE-5320-4F0C-AD25-87E715A4BEE2Q33761878-810B8F4A-D5A3-4702-8D1D-0F2D2D7D7204Q33909020-B9D20828-236C-4886-BF19-23C8E35A75C1Q34195216-4DAED8C3-1D5A-41C7-BCC2-D90D2BF5F3E5Q34323663-49C2DB2D-BDDE-4206-92AE-265D152D432AQ35067641-6884B3EA-0757-4DD9-A98C-00F0F8E55C02Q35551328-D7A51804-7872-46A8-A2B5-F835997028C2Q36014245-67B219AA-BDCA-4160-A757-442F3E1CF8DFQ36095348-944E7505-130F-4B92-A061-859E4E91662BQ36193004-AB09BDE5-FB22-424F-B69F-7A1821859007Q36895616-E463097E-A04A-4848-AEB0-34C4FA65A770Q37665427-221931ED-3486-4AD9-A523-7DF20AE0E43BQ37729313-D9ABB419-D6A3-48E7-A483-370143A728BBQ38123165-8715F418-FE19-4C25-A6D2-5A90D87806A5Q38177324-D60FD4F3-0D9D-49FE-8E27-00700994765EQ38198735-AE867108-4485-48F1-886D-E957704ECD85Q38220701-91C3EE96-C139-4D0F-AF61-83D2BFEBFBE6Q38584979-E8586608-EC31-4CE4-8236-55C026CD607BQ38730989-8FBC843B-630D-4BBB-8322-31C5F2145232Q38837469-47C20E15-0E65-4E44-8588-9A26E11A3ECDQ38912251-6E9652A7-A164-4C2B-A9DA-92926431100BQ38917897-F55FC928-3FBE-486C-AB0D-B61B19EC2085Q38988058-E2CE22E6-1CC5-457E-A0C6-3DBF1CE79671Q40657449-CFA6AA43-8D1F-4547-B582-C2CFA828C3C1Q41491084-09BD75CE-3935-4592-AE0E-78199CC39687Q41542550-DCE8BC1D-794D-468D-9D02-E66FA8F268B3Q41739849-135DB78A-792C-481D-BE99-8E92ABA96DB9Q41739878-BDDCDF5A-568D-467D-94A1-D7758FC83E00Q46794523-D6C93D19-1AB8-4CED-93F7-D7C6BE6935DAQ49788536-8AA4C655-A978-41AC-B056-59E21011DA78Q49851572-CB2B8230-DCF1-417D-A156-678A8B7B8B4CQ50125564-3A167DDF-9AF3-4808-AB86-E60DC308505DQ52348457-F5087C22-13A1-48B1-81EF-9BCC3BAB6BB4Q54329903-197741FC-44B9-4EAE-B293-FC6131CBA84BQ55285607-0A703821-CC57-4677-A210-BC50AA05126DQ55383705-67409A13-ED6B-4D90-9D0B-2CE847E390DD
P2860
Tim-3 expression defines regulatory T cells in human tumors.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Tim-3 expression defines regulatory T cells in human tumors.
@ast
Tim-3 expression defines regulatory T cells in human tumors.
@en
Tim-3 expression defines regulatory T cells in human tumors.
@nl
type
label
Tim-3 expression defines regulatory T cells in human tumors.
@ast
Tim-3 expression defines regulatory T cells in human tumors.
@en
Tim-3 expression defines regulatory T cells in human tumors.
@nl
prefLabel
Tim-3 expression defines regulatory T cells in human tumors.
@ast
Tim-3 expression defines regulatory T cells in human tumors.
@en
Tim-3 expression defines regulatory T cells in human tumors.
@nl
P2093
P2860
P1433
P1476
Tim-3 expression defines regulatory T cells in human tumors.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0058006
P407
P50
P577
2013-03-05T00:00:00Z